2015
DOI: 10.1016/j.jadohealth.2015.03.021
|View full text |Cite
|
Sign up to set email alerts
|

Use of Psychopharmacologic Medications in Adolescents With Restrictive Eating Disorders: Analysis of Data From the National Eating Disorder Quality Improvement Collaborative

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

4
19
1

Year Published

2016
2016
2021
2021

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 34 publications
(24 citation statements)
references
References 29 publications
4
19
1
Order By: Relevance
“…Also unexplored are differences in brain structure and function across different racial and ethnic groups. The majority of individuals who seek or receive treatment in North America and Europe continue to be non‐Hispanic whites, but the demographics of individuals afflicted with an eating disorder are changing, and we will need to test whether different racial and ethnic backgrounds are associated with variations in brain function (Monge et al, ). Age, sex, and ethnicity are variables that are relatively easy to define and describe.…”
Section: Development Demographic Data and Illness Statementioning
confidence: 99%
“…Also unexplored are differences in brain structure and function across different racial and ethnic groups. The majority of individuals who seek or receive treatment in North America and Europe continue to be non‐Hispanic whites, but the demographics of individuals afflicted with an eating disorder are changing, and we will need to test whether different racial and ethnic backgrounds are associated with variations in brain function (Monge et al, ). Age, sex, and ethnicity are variables that are relatively easy to define and describe.…”
Section: Development Demographic Data and Illness Statementioning
confidence: 99%
“…Prior studies have employed varying operational definitions of significant weight loss, ranging from 1.3 kg/m 2 (Wade & O'Shea, ) to 10% weight loss (Sawyer, Whitelaw, Le Grange, Yeo, & Hughes, ; Stice, Marti, & Rohde, ), with some studies not describing their operationalization (Monge et al, ). Despite this heterogeneity, studies indicate that AAN is a clinically significant ED associated with elevated eating pathology (Stice et al, ; Wade & O'Shea, ) and impairment (Stice et al, ).…”
Section: Introductionmentioning
confidence: 99%
“…The nature of the eating disturbance (e.g., restriction due to unrealistic shape and body weight concerns vs. restriction due to aversion to the sensory properties of food) distinguishes the two disorders [2]. Prior to the introduction of the ARFID diagnosis, individuals with ARFID were often referred to treatment designed for individuals with disordered eating attitudes consistent with restricting anorexia [23]. In a series of retrospective chart reviews up to 2014, 12–22 % of adolescents referred to eating disorder clinics meet criteria for ARFID rather than for a restricting eating disorder associated with weight and shape concerns and body image disturbance (e.g., [23, 24]).…”
Section: Introductionmentioning
confidence: 99%
“…Prior to the introduction of the ARFID diagnosis, individuals with ARFID were often referred to treatment designed for individuals with disordered eating attitudes consistent with restricting anorexia [23]. In a series of retrospective chart reviews up to 2014, 12–22 % of adolescents referred to eating disorder clinics meet criteria for ARFID rather than for a restricting eating disorder associated with weight and shape concerns and body image disturbance (e.g., [23, 24]). In order to show that ARFID is distinct from other restricting eating disorders, it is necessary to show that individuals with self-reported ARFID symptoms can be differentiated from those with self-reported attitudes associated with anorexia and bulimia on the basis of either comorbidity or eating behavior.…”
Section: Introductionmentioning
confidence: 99%